Interleukin-1 and acute brain injury

Frontiers in Cellular Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Murray, Katie N ^a   Parry Jones, Adrian R ^b   Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute brain injury; Cerebrovasculature; Inflammation; Interleukin 1

Indexed keywords

C REACTIVE PROTEIN; CANAKINUMAB; CRYOPYRIN; ENDOTHELIN A RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PADGEM PROTEIN; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; HIPPOCAMPUS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRACELLULAR SIGNALING; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERFUSION; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL (TOPIC); STREPTOCOCCUS PNEUMONIA; THROMBOCYTE AGGREGATION; VASCULARIZATION;

EID: 84923248240     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00018     Document Type: Article

References (228)

1. Abboud, H., Labreuche, J., Plouin, F., and Amarenco, P. (2006). High blood pressure in early acute stroke: a sign of a poor outcome? J. Hypertens. 24, 381-386. doi: 10.1097/01.hjh.0000200516.33194.e3.
2. Adhya, S., Johnson, G., Herbert, J., Jaggi, H., Babb, J. S., Grossman, R. I., et al. (2006). Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33, 1029-1035. doi: 10.1016/j.neuroimage.2006.08.008.
3. Afshar-Kharghan, V., and Thiagarajan, P. (2006). Leukocyte adhesion and thrombosis. Curr. Opin. Hematol. 13, 34-39. doi: 10.1097/01.moh.0000190107.54790.de.
4. Ajmone-Cat, M. A., Cacci, E., Ragazzoni, Y., Minghetti, L., and Biagioni, S. (2010). Pro-gliogenic effect of IL-1alpha in the differentiation of embryonic neural precursor cells in vitro. J. Neurochem. 113, 1060-1072. doi: 10.1111/j.1471-4159.2010.06670.x.
5. Albers, G. W., Goldstein, L. B., Hess, D. C., Wechsler, L. R., Furie, K. L., Gorelick, P. B., et al. (2011). Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 42, 2645-2650. doi: 10.1161/strokeaha.111.618850.
6. Allan, S. M., and Rothwell, N. J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734-744. doi: 10.1038/sj.mp.4000223.
7. Allan, S. M., and Rothwell, N. J. (2003). Inflammation in central nervous system injury. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358, 1669-1677. doi: 10.1098/rstb.2003.1358.
8. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640. doi: 10.1038/nri1664.
9. Anderson, M. F., Aberg, M. A. I., Nilsson, M., and Eriksson, P. S. (2002). Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res. Dev. Brain Res. 134, 115-122. doi: 10.1016/s0165-3806(02)00277-8.
10. Andrews, A. E., Barcham, G. J., Brandon, M. R., and Nash, A. D. (1991). Molecular cloning and characterization of ovine IL-1 alpha and IL-1 beta. Immunology 74, 453-460.
11. Anfossi, G., Russo, I., Doronzo, G., Pomero, A., and Trovati, M. (2010). Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm. 2010:174341. doi: 10.1155/2010/174341.
12. Arsava, E. M., Vural, A., Akpinar, E., Gocmen, R., Akcalar, S., Oguz, K. K., et al. (2014). The detrimental effect of aging on leptomeningeal collaterals in ischemic stroke. J. Stroke Cerebrovasc. Dis. 23, 421-426. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.014.
13. Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970. doi: 10.1038/nm747.
14. Asano, T., and Sano, K. (1977). Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs. J. Neurosurg. 46, 454-466. doi: 10.3171/jns.1977.46.4.0454.
15. Austin, B. P., Nair, V. A., Meier, T. B., Xu, G., Rowley, H. A., Carlsson, C. M., et al. (2011). Effects of hypoperfusion in Alzheimer’s disease. J. Alzheimers. Dis. 26(Suppl. 3), 123-133. doi: 10.3233/JAD-2011-0010.
16. Banasr, M., Valentine, G. W., Li, X.-Y., Gourley, S. L., Taylor, J. R., and Duman, R. S. (2007). Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol. Psychiatry 62, 496-504. doi: 10.1016/j.biopsych.2007.02.006.
17. Banwell, V., Sena, E. S., and Macleod, M. R. (2009). Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J. Stroke Cerebrovasc. Dis. 18, 269-276. doi: 10.1016/j.jstrokecerebrovasdis.2008.11.009.
18. Belayev, L., Pinard, E., Nallet, H., Seylaz, J., Liu, Y., Riyamongkol, P., et al. (2002). Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 33, 1077-1084. doi: 10.1161/hs0402.105555.
19. Ben Menachem-Zidon, O., Goshen, I., Kreisel, T., Ben Menahem, Y., Reinhartz, E., Ben Hur, T., et al. (2008). Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology 33, 2251-2262. doi: 10.1038/sj.npp.1301606.
20. Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., Issafras, H., et al. (2011). Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Atherosclerosis 216, 313-320. doi: 10.1016/j.atherosclerosis.2011.02.026.
21. Bodenant, M., Kuulasmaa, K., Wagner, A., Kee, F., Palmieri, L., Ferrario, M. M., et al. (2011). Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 42, 2872-2877. doi: 10.1161/strokeaha.111.614099.
22. Bogiatzi, C., Hackam, D. G., McLeod, A. I., and Spence, J. D. (2014). Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 45, 3208-3213. doi: 10.1161/strokeaha.114.006536.
23. Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., and Rothwell, N. J. (2001). Role of IL-1αand IL-1β in ischemic brain damage. J. Neurosci. 21, 5528-5534.
24. Braunersreuther, V., Steffens, S., Arnaud, C., Pelli, G., Burger, F., Proudfoot, A., et al. (2008). A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler. Thromb. Vasc. Biol. 28, 1090-1096. doi: 10.1161/atvbaha.108.165423.
25. Bryant, A. E., Bayer, C. R., Chen, R. Y. Z., Guth, P. H., Wallace, R. J., and Stevens, D. L. (2005). Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J. Infect. Dis. 192, 1014-1022. doi: 10.1086/432729.
26. Butcher, J. T., Goodwill, A. G., Stanley, S. C., and Frisbee, J. C. (2013). Differential impact of dilator stimuli on increased myogenic activation of cerebral and skeletal muscle resistance arterioles in obese zucker rats. Microcirculation 20, 579-589. doi: 10.1111/micc.12056.
27. Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., et al. (2004). VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 36, 827-835. doi: 10.1038/ng1395.
28. Cao, Y.-J., Wang, Y.-M., Zhang, J., Zeng, Y.-J., and Liu, C.-F. (2009). The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction. J. Thromb. Thrombolysis 27, 233-238. doi: 10.1007/s11239-007-0190-x.
29. Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., et al. (2009). The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J. Immunol. 183, 4705-4714. doi: 10.4049/jimmunol.0901511.
30. Chakraborty, A., Tannenbaum, S., Rordorf, C., Lowe, P. J., Floch, D., Gram, H., et al. (2012). Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody. Clin. Pharmacokinet. 51, e1-e18. doi: 10.2165/11599820-000000000-00000.
31. Chakraborty, A., Van, L. M., Skerjanec, A., Floch, D., Klein, U. R., Krammer, G., et al. (2013). Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis. J. Clin. Pharmacol. 53, 1240-1251. doi: 10.1002/jcph.162.
32. Chamberlain, J., Francis, S., Brookes, Z., Shaw, G., Graham, D., Alp, N. J., et al. (2009). Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS One 4:e5073. doi: 10.1371/journal.pone.0005073.
33. Charakida, M., Donald, A. E., Terese, M., Leary, S., Halcox, J. P., Ness, A., et al. (2005). Endothelial dysfunction in childhood infection. Circulation 111, 1660-1665. doi: 10.1161/01.cir.0000160365.18879.1c.
34. Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., and Rock, K. L. (2007). Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856. doi: 10.1038/nm1603.
35. Chen, Z. M., Sandercock, P., Pan, H. C., Counsell, C., Collins, R., Liu, L. S., et al. (2000). Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 31, 1240-1249. doi: 10.1161/01.str.31.6.1240.
36. Chu, H. X., Kim, H. A., Lee, S., Moore, J. P., Chan, C. T., Vinh, A., et al. (2014). Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J. Cereb. Blood Flow Metab. 34, 450-459. doi: 10.1038/jcbfm.2013.217.
37. Church, L. D., and McDermott, M. F. (2010). Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes. Expert Rev. Clin. Immunol. 6, 831-841. doi: 10.1586/eci.10.66.
38. Clark, D., Tuor, U. I., Thompson, R., Institoris, A., Kulynych, A., Zhang, X., et al. (2012). Protection against recurrent stroke with resveratrol: endothelial protection. PLoS One 7:e47792. doi: 10.1371/journal.pone.0047792.
39. Clayton, T. C., Thompson, M., and Meade, T. W. (2008). Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur. Heart J. 29, 96-103. doi: 10.1093/eurheartj/ehm516.
40. Corbyn, Z. (2014). Statistics: a growing global burden. Nature 510, S2-S3. doi: 10.1038/510s2a.
41. Coxon, A., Bolon, B., Estrada, J., Kaufman, S., Scully, S., Rattan, A., et al. (2002). Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum. 46, 2604-2612. doi: 10.1002/art.10546.
42. Cuartero, M. I., Ballesteros, I., Moraga, A., Nombela, F., Vivancos, J., Hamilton, J. A., et al. (2013). N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke 44, 3498-3508. doi: 10.1161/strokeaha.113.002470.
43. del Rey, A., Balschun, D., Wetzel, W., Randolf, A., and Besedovsky, H. O. (2013). A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6 and TNFαoperates during long-term potentiation and learning. Brain. Behav. Immun. 33, 15-23. doi: 10.1016/j.bbi.2013.05.011.
44. del Zoppo, G. J., Schmid-Schönbein, G. W., Mori, E., Copeland, B. R., and Chang, C. M. (1991). Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22, 1276-1283. doi: 10.1161/01.str.22.10.1276.
45. D’Haeseleer, M., Beelen, R., Fierens, Y., Cambron, M., Vanbinst, A., Verborgh, C., et al. (2013). Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc. Natl. Acad. Sci. U S A 110, 5654-5658. doi: 10.1073/pnas.1222560110.
46. Dénes, A., Humphreys, N., Lane, T. E., Grencis, R., and Rothwell, N. (2010). Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 30, 10086-10095. doi: 10.1523/jneurosci.1227-10.2010.
47. Dénes, Á., Pradillo, J. M., Drake, C., Sharp, A., Warn, P., Murray, K. N., et al. (2014). Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα. Ann. Neurol. 75, 670-683. doi: 10.1002/ana.24146.
48. Denes, A., Thornton, P., Rothwell, N. J., and Allan, S. M. (2010). Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain. Behav. Immun. 24, 708-723. doi: 10.1016/j.bbi.2009.09.010.
49. Deng, J., Zhang, J., Feng, C., Xiong, L., and Zuo, Z. (2014). Critical role of matrix metalloprotease-9 in chronic high fat diet-induced cerebral vascular remodelling and increase of ischaemic brain injury in mice†. Cardiovasc. Res. 103, 473-484. doi: 10.1093/cvr/cvu154.
50. Diedler, J., Sykora, M., Hahn, P., Rupp, A., Rocco, A., Herweh, C., et al. (2009). C-reactive-protein levels associated with infection predict short-and long-term outcome after supratentorial intracerebral hemorrhage. Cerebrovasc. Dis. 27, 272-279. doi: 10.1159/000199465.
51. Dinarello, C. A. (1994). Interleukin-1 antagonists. J. Interferon Res. 14, 307. doi: 10.2165/00128413-199308720-00015.
52. Dinarello, C. A. (2011). A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur. J. Immunol. 41, 1203-1217. doi: 10.1002/eji.201141550.
53. Dóczi, T. (1985). The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies. Acta Neurochir. (Wien) 77, 110-132. doi: 10.1007/bf01476215.
54. Doll, D. N., Barr, T. L., and Simpkins, J. W. (2014). Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis. 5, 294-306. doi: 10.14336/ad.2014.0500294.
55. Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., et al. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361. doi: 10.1038/nature08938.
56. Dziedzic, T., Slowik, A., Pera, J., and Szczudlik, A. (2005). Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovasc. Dis. 20, 299-303. doi: 10.1159/000087928.
57. Eickhoff, T. C., Sherman, I. L., and Serfling, R. E. (1961). Observations on excess mortality associated with epidemic influenza. JAMA 176, 776-782. doi: 10.1001/jama.1961.03040220024005.
58. Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U S A 100, 13632-13637. doi: 10.1073/pnas.2234031100.
59. Elkind, M. S. V. (2010). Impact of innate inflammation in population studies. Ann. NYAcad.Sci.1207,97-106.doi:10.1111/j.1749-6632.2010.05736.x.
60. Emsley, H. C., and Hopkins, S. J. (2008). Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 7, 341-353. doi: 10.1016/s1474-4422(08)70061-9.
61. Emsley, H. C. A., Smith, C. J., Georgiou, R. F., Vail, A., Hopkins, S. J., Rothwell, N. J., et al. (2005). A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76, 1366-1372. doi: 10.1136/jnnp.2004.054882.
62. Enzmann, G., Mysiorek, C., Gorina, R., Cheng, Y.-J., Ghavampour, S., Hannocks, M.-J., et al. (2013). The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 125, 395-412. doi: 10.1007/s00401-012-1076-3.
63. Fann, D. Y.-W., Lee, S. Y., Manzanero, S., Tang, S. C., Gelderblom, M., Chunduri, P., et al. (2013). Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 4:e790. doi: 10.1038/cddis.2013.326.
64. Ferroni, P., Basili, S., Falco, A., and Davì, G. (2004). Platelet activation in type 2 diabetes mellitus. J. Thromb. Haemost. 2, 1282-1291. doi: 10.1111/j.1538-7836.2004.00836.x.
65. Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., et al. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250. doi: 10.1161/strokeaha.108.541128.
66. Fouda, A. Y., Kozak, A., Alhusban, A., Switzer, J. A., and Fagan, S. C. (2013). Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: hypertension blunts the response. Exp. Transl. Stroke Med. 5:12. doi: 10.1186/2040-7378-5-12.
67. Gage, F. H., Coates, P. W., Palmer, T. D., Kuhn, H. G., Fisher, L. J., Suhonen, J. O., et al. (1995). Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U S A 92, 11879-11883. doi: 10.1073/pnas.92.25.11879.
68. Gebicke-Haerter, P. J., Spleiss, O., Ren, L. Q., Li, H., Dichmann, S., Norgauer, J., et al. (2001). Microglial chemokines and chemokine receptors. Prog. Brain Res. 132, 525-532. doi: 10.1016/s0079-6123(01)32100-3.
69. Girard, S., Murray, K. N., Rothwell, N. J., Metz, G. A. S., and Allan, S. M. (2014). Long-term functional recovery and compensation after cerebral ischemia in rats. Behav. Brain Res. 270, 18-28. doi: 10.1016/j.bbr.2014.05.008.
70. Gkaliagkousi, E., Corrigall, V., Becker, S., de Winter, P., Shah, A., Zamboulis, C., et al. (2009). Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur. Heart J. 30, 3048-3054. doi: 10.1093/eurheartj/ehp330.
71. Goldbach-Mansky, R., Shroff, S. D., Wilson, M., Snyder, C., Plehn, S., Barham, B., et al. (2008). A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 58, 2432-2442. doi: 10.1002/art.23620.
72. Granger, D. N., Rodrigues, S. F., Yildirim, A., and Senchenkova, E. Y. (2010). Microvascular responses to cardiovascular risk factors. Microcirculation 17, 192-205. doi: 10.1111/j.1549-8719.2009.00015.x.
73. Grau, A. J., Buggle, F., Heindl, S., Steichen-Wiehn, C., Banerjee, T., Maiwald, M., et al. (1995). Recent infection as a risk factor for cerebrovascular ischemia. Stroke 26, 373-379. doi: 10.1161/01.str.26.3.373.
74. Grau, A. J., Urbanek, C., and Palm, F. (2010). Common infections and the risk of stroke. Nat. Rev. Neurol. 6, 681-694. doi: 10.1038/nrneurol.2010.163.
75. Greenhalgh, A. D., Brough, D., Robinson, E. M., Girard, S., Rothwell, N. J., and Allan, S. M. (2012). Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis. Model. Mech. 5, 823-833. doi: 10.1242/dmm.008557.
76. Greenhalgh, A. D., Galea, J., Dénes, A., Tyrrell, P. J., and Rothwell, N. J. (2010). Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection. Br. J. Pharmacol. 160, 153-159. doi: 10.1111/j.1476-5381.2010.00684.x.
77. Grüner, S., Prostredna, M., Koch, M., Miura, Y., Schulte, V., Jung, S. M., et al. (2005). Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. Blood 105, 1492-1499. doi: 10.1182/blood-2004-06-2391.
78. Hacke, W., and Lichy, C. (2008). Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial? Nat. Clin. Pract. Neurol. 4, 474-475. doi: 10.1038/ncpneuro0867.
79. Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., et al. (2014). Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55-60. doi: 10.1038/nature13165.
80. Hankey, G. J. (2006). Potential new risk factors for ischemic stroke: what is their potential? Stroke 37, 2181-2188. doi: 10.1161/01.str.0000229883.72010.e4.
81. Haramaki, N., Ikeda, H., Takenaka, K., Katoh, A., Sugano, R., Yamagishi, S., et al. (2007). Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arterioscler. Thromb. Vasc. Biol. 27, 1471-1477. doi: 10.1161/atvbaha.106.128793.
82. Harris, A. K., Elgebaly, M. M., Li, W., Sachidanandam, K., and Ergul, A. (2008). Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1213-R1219. doi: 10.1152/ajpregu.00885.2007.
83. Hawrylowicz, C. M., Howells, G. L., and Feldmann, M. (1991). Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J. Exp. Med. 174, 785-790. doi: 10.1084/jem.174.4.785.
84. Hayakawa, K., Pham, L.-D. D., Katusic, Z. S., Arai, K., and Lo, E. H. (2012). Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc. Natl. Acad. Sci. U S A 109, 7505-7510.doi: 10.1073/pnas.1121146109.
85. Helmy, A., Guilfoyle, M. R., Carpenter, K. L. H., Pickard, J. D., Menon, D. K., and Hutchinson, P. J. (2014). Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial. J. Cereb. Blood Flow Metab. 34, 845-851. doi: 10.1038/jcbfm.2014.23.
86. Hoehn, B. D., Palmer, T. D., and Steinberg, G. K. (2005). Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 36, 2718-2724. doi: 10.1161/01.str.0000190020.30282.cc.
87. Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., et al. (2008). Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 58, 2443-2452. doi: 10.1002/art.23687.
88. Hopkins, S. J., and Rothwell, N. J. (1995). Cytokines and the nervous system. I: expression and recognition. Trends Neurosci. 18, 83-88. doi: 10.1016/0166-2236(95)93881-w.
89. Hou, Q., Zuo, Z., Michel, P., Zhang, Y., Eskandari, A., Man, F., et al. (2013). Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. Stroke 44, 3557-3560. doi: 10.1161/strokeaha.113.003150.
90. Howard, C., Noe, A., Skerjanec, A., Holzhauer, B., Wernsing, M., Ligueros-Saylan, M., et al. (2014). Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies. Cardiovasc. Diabetol. 13:94. doi: 10.1186/1475-2840-13-94.
91. Howells, D. W., Porritt, M. J., Rewell, S. S. J., O’Collins, V., Sena, E. S., van der Worp, H. B., et al. (2010). Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 1412-1431. doi: 10.1038/jcbfm.2010.66.
92. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808. doi: 10.1038/nm.2399.
93. Ito, U., Hakamata, Y., Kawakami, E., and Oyanagi, K. (2011). Temporary [corrected] cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to delayed [corrected] focal cortical infarction. J. Cereb. Blood Flow Metab. 31, 328-338. doi: 10.1038/jcbfm.2010.97.
94. Jackman, K., and Iadecola, C. (2015). Neurovascular regulation in the ischemic brain. Antioxid. Redox Signal. 22, 149-160. doi: 10.1089/ars.2013.5669.
95. Jenny, N. S., Tracy, R. P., Ogg, M. S., Luong, L. A., Kuller, L. H., Arnold, A. M., et al. (2002). In the elderly, interleukin-6 plasma levels and the-174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22, 2066-2071. doi: 10.1161/01.atv.0000040224.49362.60.
96. Jin, R., Yang, G., and Li, G. (2010). Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779-789. doi: 10.1189/jlb.1109766.
97. Kim, H., Hysi, P. G., Pawlikowska, L., Poon, A., Burchard, E. G., Zaroff, J. G., et al. (2009). Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc. Dis. 27, 176-182. doi: 10.1159/000185609.
98. Kim, E., Tolhurst, A. T., and Cho, S. (2014). Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury. J. Neuroinflammation 11:83. doi: 10.1186/1742-2094-11-83.
99. Kirby, D. M., Rennie, K. J., Smulders-Srinivasan, T. K., Acin-Perez, R., Whittington, M., Enriquez, J.-A., et al. (2009). Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Prolif. 42, 413-424. doi: 10.1111/j.1365-2184.2009.00612.x.
100. Klementiev, B., Li, S., Korshunova, I., Dmytriyeva, O., Pankratova, S., Walmod, P. S., et al. (2014). Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist. J. Neuroinflammation 11:27. doi: 10.1186/1742-2094-11-27.
101. Kokaia, Z., Thored, P., Arvidsson, A., and Lindvall, O. (2006). Regulation of stroke-induced neurogenesis in adult brain-recent scientific progress. Cereb. Cortex 16, i16-i17. doi: 10.1093/cercor/bhj174.
102. Koo, J. W., and Duman, R. S. (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U S A 105, 751-756. doi: 10.1073/pnas.0708092105.
103. Kuemmerle-Deschner, J. B., Ramos, E., Blank, N., Roesler, J., Felix, S. D., Jung, T., et al. (2011). Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res. Ther. 13:R34. doi: 10.1186/ar3266.
104. Kuhn, H. G., Dickinson-Anson, H., and Gage, F. H. (1996). Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16, 2027-2033.
105. Kunze, A. K., Annecke, A., Wigger, F., Lichy, C., Buggle, F., Schnippering, H., et al. (2000). Recent infection as a risk factor for intracerebral and subarachnoid hemorrhages. Cerebrovasc. Dis. 10, 352-358. doi: 10.1159/000016090.
106. Kwan, J., Horsfield, G., Bryant, T., Gawne-Cain, M., Durward, G., Byrne, C. D., et al. (2013). IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke. Exp. Gerontol. 48, 960-965. doi: 10.1016/j.exger.2013.07.003.
107. Lakhan, S. E., Kirchgessner, A., and Hofer, M. (2009). Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7:97. doi: 10.1186/1479-5876-7-97.
108. Lambertsen, K. L., Biber, K., and Finsen, B. (2012). Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 32, 1677-1698. doi: 10.1038/jcbfm.2012.88.
109. Lapchak, P. A., Araujo, D. M., Song, D., and Zivin, J. A. (2002). The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke. Stroke 33, 147-152. doi: 10.1161/hs0102.100530.
110. Lapi, D., Mastantuono, T., Sapio, D., Paterni, M., and Colantuoni, A. (2013). Pial microvascular responses induced by transient bilateral common carotid artery occlusion in Zucker rats. Clin. Hemorheol. Microcirc. 54, 415-429. doi: 10.3233/CH-131763.
111. Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., and Mandrup-Poulsen, T. (2009). Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32, 1663-1668. doi: 10.2337/dc09-0533.
112. Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., et al. (2007). Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526. doi: 10.1056/NEJMoa065213.
113. Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., and Strong, A. J. (2011). Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage and traumatic brain injury. J. Cereb. Blood Flow Metab. 31, 17-35. doi: 10.1038/jcbfm.2010.191.
114. Lawes, C. M. M., Bennett, D. A., Feigin, V. L., and Rodgers, A. (2004). Blood pressure and stroke: an overview of published reviews. Stroke 35, 776-785. doi: 10.1161/01.str.0000126208.14181.dd.
115. Lawrence, C. B., Allan, S. M., and Rothwell, N. J. (1998). Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 10, 1188-1195. doi: 10.1046/j.1460-9568.1998.00136.x.
116. Le Behot, A., Gauberti, M., Martinez De Lizarrondo, S., Montagne, A., Lemarchand, E., Repesse, Y., et al. (2014). GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice. Blood 123, 3354-3363. doi: 10.1182/blood-2013-12-543074.
117. Lee, S., Shafe, A. C. E., and Cowie, M. R. (2011). UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the general practice research database. BMJ Open 1:e000269. doi: 10.1136/bmjopen-2011-000269.
118. Li, D., Huang, B., Liu, J., Li, L., and Li, X. (2013a). Decreased brain K(ATP) channel contributes to exacerbating ischemic brain injury and the failure of neuroprotection by sevoflurane post-conditioning in diabetic rats. PLoS One 8:e73334. doi: 10.1371/journal.pone.0073334.
119. Li, W., Prakash, R., Chawla, D., Du, W., Didion, S. P., Filosa, J. A., et al. (2013b). Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R1001-R1008. doi: 10.1152/ajpregu.00523.2012.
120. Li, W., Qu, Z., Prakash, R., Chung, C., Ma, H., Hoda, M. N., et al. (2013c). Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res. 1541, 106-114. doi: 10.1016/j.brainres.2013.10.021.
121. Lian, H., Shim, D. J., Gaddam, S. S. K., Rodriguez-Rivera, J., Bitner, B. R., Pautler, R. G., et al. (2012). IK Bαdeficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery. Mol. Neurodegener. 7:47. doi: 10.1186/1750-1326-7-47.
122. Liu, Z., Fan, Y., Won, S. J., Neumann, M., Hu, D., Zhou, L., et al. (2007). Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 38, 146-152. doi: 10.1161/01.str.0000251791.64910.cd.
123. Liu, J., Gao, B.-B., Clermont, A. C., Blair, P., Chilcote, T. J., Sinha, S., et al. (2011). Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat. Med. 17, 206-210.doi: 10.1038/nm.2295.
124. Liu, T., McDonnell, P. C., Young, P. R., White, R. F., Siren, A. L., Hallenbeck, J. M., et al. (1993). Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke 24, 1746-1750. doi: 10.1161/01.str.24.11.1746.
125. Luheshi, N. M., Kovács, K. J., Lopez-Castejon, G., Brough, D., and Denes, A. (2011). Interleukin-1αexpression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. J. Neuroinflammation 8:186. doi: 10.1186/1742-2094-8-186.
126. Luheshi, N. M., Rothwell, N. J., and Brough, D. (2009). Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br. J. Pharmacol. 157, 1318-1329. doi: 10.1111/j.1476-5381.2009.00331.x.
127. Ma, Q., Chen, S., Hu, Q., Feng, H., Zhang, J. H., and Tang, J. (2014). NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann. Neurol. 75, 209-219. doi: 10.1002/ana.24070.
128. Maher, C. O., Anderson, R. E., Martin, H. S., McClelland, R. L., and Meyer, F. B. (2003). Interleukin-1beta and adverse effects on cerebral blood flow during long-term global hypoperfusion. J. Neurosurg. 99, 907-912. doi: 10.3171/jns.2003.99.5.0907.
129. Mathieu, P., Piantanida, A. P., and Pitossi, F. (2010). Chronic expression of transforming growth factor-beta enhances adult neurogenesis. Neuroimmunomodulation 17, 200-201. doi: 10.1159/000258723.
130. McCabe, C., Gallagher, L., Gsell, W., Graham, D., Dominiczak, A. F., and Macrae, I. M. (2009). Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke 40, 3864-3868. doi: 10.1161/strokeaha.109.559021.
131. McColl, B. W., Allan, S. M., and Rothwell, N. J. (2009). Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158, 1049-1061. doi: 10.1016/j.neuroscience.2008.08.019.
132. McColl, B. W., Rose, N., Robson, F. H., Rothwell, N. J., and Lawrence, C. B. (2010). Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J. Cereb. Blood Flow Metab. 30, 267-272. doi: 10.1038/jcbfm.2009.217.
133. McColl, B. W., Rothwell, N. J., and Allan, S. M. (2007). Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanisms. J. Neurosci. 27, 4403-4412. doi: 10.1523/jneurosci.5376-06.2007.
134. McKellar, G. E., McCarey, D. W., Sattar, N., and McInnes, I. B. (2009). Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat. Rev. Cardiol. 6, 410-417. doi: 10.1038/nrcardio.2009.57.
135. Mertens, M., and Singh, J. A. (2009). Anakinra for rheumatoid arthritis: a systematic review.. J. Rheumatol. 36, 1118-1125. doi: 10.3899/jrheum.090074.
136. Minnerup, J., Sutherland, B. A., Buchan, A. M., and Kleinschnitz, C. (2012). Neuroprotection for stroke: current status and future perspectives. Int. J. Mol. Sci. 13, 11753-11772. doi: 10.3390/ijms130911753.
137. Miwa, K., Tanaka, M., Okazaki, S., Furukado, S., Sakaguchi, M., Mochizuki, H., et al. (2013). Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors. Arterioscler. Thromb. Vasc. Biol. 33, 400-405. doi: 10.1161/atvbaha.112.300350.
138. Moncada, S., and Higgs, E. A. (2006). The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147(Suppl. 1), S193-S201. doi: 10.1038/sj.bjp.0706458.
139. Monje, M. L., and Palmer, T. (2003). Radiation injury and neurogenesis. Curr. Opin. Neurol. 16, 129-134. doi: 10.1097/00019052-200304000-00002.
140. Monje, M. L., Toda, H., and Palmer, T. D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765. doi: 10.1126/science.1088417.
141. Moreno-López, B., Romero-Grimaldi, C., Noval, J. A., Murillo-Carretero, M., Matarredona, E. R., and Estrada, C. (2004). Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J. Neurosci. 24, 85-95. doi: 10.1523/jneurosci.1574-03.2004.
142. Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., et al. (2010). The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 56, 1113-1132. doi: 10.1016/j.jacc.2010.05.034.
143. Muhammad, S., Haasbach, E., Kotchourko, M., Strigli, A., Krenz, A., Ridder, D. A., et al. (2011). Influenza virus infection aggravates stroke outcome. Stroke 42, 783-791. doi: 10.1161/STROKEAHA.110.596783.
144. Mulcahy, N. J., Ross, J., Rothwell, N. J., and Loddick, S. A. (2003). Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 140, 471-476. doi: 10.1038/sj.bjp.0705462.
145. Murray, K. N., Buggey, H. F., Denes, A., and Allan, S. M. (2013). Systemic immune activation shapes stroke outcome. Mol. Cell. Neurosci. 53, 14-25. doi: 10.1016/j.mcn.2012.09.004.
146. Murray, K. N., Girard, S., Holmes, W. M., Parkes, L. M., Williams, S. R., Parry-Jones, A. R., et al. (2014). Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia. Stroke 45, 3412-3419. doi: 10.1161/strokeaha.114.006613.
147. Nehls, V., and Drenckhahn, D. (1993). The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry 99, 1-12. doi: 10.1007/bf00268014.
148. Nih, L. R., Deroide, N., Leré-Déan, C., Lerouet, D., Soustrat, M., Levy, B. I., et al. (2012). Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration. Eur. J. Neurosci. 35, 1208-1217. doi: 10.1111/j.1460-9568.2012.08041.x.
149. Nowakowski, R. S., Lewin, S. B., and Miller, M. W. (1989). Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J. Neurocytol. 18, 311-318. doi: 10.1007/bf01190834.
150. O’Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., and Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467-477. doi: 10.1002/ana.20741.
151. Ohab, J. J., and Carmichael, S. T. (2008). Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist 14, 369-380. doi: 10.1177/1073858407309545.
152. Ohira, T., Shahar, E., Chambless, L. E., Rosamond, W. D., Mosley, T. H., and Folsom, A. R. (2006). Risk factors for ischemic stroke subtypes: the atherosclerosis risk in communities study. Stroke 37, 2493-2498. doi: 10.1161/01.str.0000239694.19359.88.
153. Ohtsuki, T., Ruetzler, C. A., Tasaki, K., and Hallenbeck, J. M. (1996). Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 16, 1137-1142. doi: 10.1097/00004647-199611000-00007.
154. Oppenheimer, S. M., Hoffbrand, B. I., Oswald, G. A., and Yudkin, J. S. (1985). Diabetes mellitus and early mortality from stroke. Br. Med. J. (Clin. Res. Ed) 291, 1014-1015. doi: 10.1136/bmj.291.6505.1349-a.
155. Pabbidi, M. R., Juncos, J., Juncos, L., Renic, M., Tullos, H. J., Lazar, J., et al. (2013). Identification of a region of rat chromosome 1 that impairs the myogenic response and autoregulation of cerebral blood flow in fawn-hooded hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 304, H311-H317. doi: 10.1152/ajpheart.00622.2012.
156. Packard, R. R. S., Lichtman, A. H., and Libby, P. (2009). Innate and adaptive immunity in atherosclerosis. Semin. Immunopathol. 31, 5-22. doi: 10.1007/s00281-009-0153-8.
157. Paez-Gonzalez, P., Asrican, B., Rodriguez, E., and Kuo, C. T. (2014). Identification of distinct ChAT(+) neurons and activity-dependent control of postnatal SVZ neurogenesis. Nat. Neurosci. 17, 934-942. doi: 10.1038/nn.3734.
158. Paganini-Hill, A., Lozano, E., Fischberg, G., Perez Barreto, M., Rajamani, K., Ameriso, S. F., et al. (2003). Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke 34, 452-457. doi: 10.1161/01.str.0000053451.28410.98.
159. Palomares, S. M., and Cipolla, M. J. (2014). Myogenic tone as a therapeutic target for ischemic stroke. Curr. Vasc. Pharmacol. 12, 788-800. doi: 10.2174/15701611113116660155.
160. Parry-Jones, A., Boutin, H., Denes, A., McColl, B., Hopkins, S., Allan, S., et al. (2010). Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up? J. Stroke Cerebrovasc. Dis. 19, 512-513. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.005.
161. Parry-Jones, A. R., Liimatainen, T., Kauppinen, R. A., Gröhn, O. H. J., and Rothwell, N. J. (2008). Interleukin-1 exacerbates focal cerebral ischemia and reduces ischemic brain temperature in the rat. Magn. Reson. Med. 59, 1239-1249. doi: 10.1002/mrm.21531.
162. Patel, A., Jagadesham, V. P., Porter, K. E., Scott, D. J. A., and Carding, S. R. (2008). Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Eur. J. Vasc. Endovasc. Surg. 36, 20-27. doi: 10.1016/j.ejvs.2008.01.014.
163. Pham, L.-D. D., Hayakawa, K., Seo, J. H., Nguyen, M.-N., Som, A. T., Lee, B. J., et al. (2012). Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 60, 875-881. doi: 10.1002/glia.22320.
164. Pham, M., Helluy, X., Kleinschnitz, C., Kraft, P., Bartsch, A. J., Jakob, P., et al. (2011). Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla. PLoS One 6:e18386. doi: 10.1371/journal.pone.0018386.
165. Pieper, C., Marek, J. J., Unterberg, M., Schwerdtle, T., and Galla, H.-J. (2014). Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro. Brain Res. 1550, 1-8. doi: 10.1016/j.brainres.2014.01.004.
166. Pinteaux, E., Parker, L. C., Rothwell, N. J., and Luheshi, G. N. (2002). Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83, 754-763. doi: 10.1046/j.1471-4159.2002.01184.x.
167. Pires, P. W., Girgla, S. S., McClain, J. L., Kaminski, N. E., van Rooijen, N., and Dorrance, A. M. (2013). Improvement in middle cerebral artery structure and endothelial function in stroke-prone spontaneously hypertensive rats after macrophage depletion. Microcirculation 20, 650-661. doi: 10.1111/micc.12064.
168. Pleiner, J., Schaller, G., Mittermayer, F., Zorn, S., Marsik, C., Polterauer, S., et al. (2004). Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 110, 3349-3354. doi: 10.1161/01.cir.0000147774.90396.ed.
169. Pradillo, J. M., Denes, A., Greenhalgh, A. D., Boutin, H., Drake, C., McColl, B. W., et al. (2012). Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab. 32, 1810-1819. doi: 10.1038/jcbfm.2012.101.
170. Pugazhenthi, S., Zhang, Y., Bouchard, R., and Mahaffey, G. (2013). Induction of an inflammatory loop by interleukin-1β and tumor necrosis factor-αinvolves NF-kB and STAT-1 in differentiated human neuroprogenitor cells. PLoS One 8:e69585. doi: 10.1371/journal.pone.0069585.
171. Pulsinelli, W. A., Levy, D. E., Sigsbee, B., Scherer, P., and Plum, F. (1983). Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am. J. Med. 74, 540-544. doi: 10.1016/0002-9343(83)91035-5.
172. Razinia, T., Saver, J. L., Liebeskind, D. S., Ali, L. K., Buck, B., and Ovbiagele, B. (2007). Body mass index and hospital discharge outcomes after ischemic stroke. Arch. Neurol. 64, 388-391. doi: 10.1001/archneur.64.3.388.
173. Rewell, S. S. J., Fernandez, J. A., Cox, S. F., Spratt, N. J., Hogan, L., Aleksoska, E., et al. (2010). Inducing stroke in aged, hypertensive, diabetic rats. J. Cereb. Blood Flow Metab. 30, 729-733. doi: 10.1038/jcbfm.2009.273.
174. Reynolds, B. A., and Weiss, S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710.doi: 10.1126/science.1553558.
175. Rezaii, A. A., Hoseinipanah, S. M., Hajilooi, M., Rafiei, A. R., Shikh, N., and Haidari, M. (2009). Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. Immunol. Invest. 38, 220-230. doi: 10.1080/08820130902745146.
176. Ridker, P. M., Thuren, T., Zalewski, A., and Libby, P. (2011). Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am. Heart J. 162, 597-605. doi: 10.1016/j.ahj.2011.06.012.
177. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., et al. (2011). Heart disease and stroke statistics-2011 update: a report from the american heart association. Circulation 123, e18-e209. doi: 10.1161/CIR.0b013e3182009701.
178. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126. doi: 10.1056/nejm199906173402418.
179. Ross, J., Brough, D., Gibson, R. M., Loddick, S. A., and Rothwell, N. J. (2007). A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat. Neuropharmacology 53, 638-642. doi: 10.1016/j.neuropharm.2007.07.015.
180. Rost, N. S., Wolf, P. A., Kase, C. S., Kelly-Hayes, M., Silbershatz, H., Massaro, J. M., et al. (2001). Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32, 2575-2579. doi: 10.1161/hs1101.098151.
181. Rothwell, N. (2003). Interleukin-1 and neuronal injury: mechanisms, modification and therapeutic potential. Brain. Behav. Immun. 17, 152-157. doi: 10.1016/s0889-1591(02)00098-3.
182. Rothwell, N. J., and Luheshi, G. N. (2000). Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618-625. doi: 10.1016/s0166-2236(00)01661-1.
183. Ruggeri, Z. M. (2003). Von Willebrand factor, platelets and endothelial cell interactions. J. Thromb. Haemost. 1, 1335-1342. doi: 10.1046/j.1538-7836.2003.00260.x.
184. Schwartz, M., London, A., and Shechter, R. (2009). Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience 158, 1133-1142. doi: 10.1016/j.neuroscience.2008.12.013.
185. Seki, T., and Arai, Y. (1995). Age-related production of new granule cells in the adult dentate gyrus. Neuroreport 6, 2479-2482. doi: 10.1097/00001756-199512150-00010.
186. Seripa, D., Dobrina, A., Margaglione, M., Matera, M. G., Gravina, C., Vecile, E., et al. (2003). Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc. Dis. 15, 276-281. doi: 10.1159/000069497.
187. Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., et al. (2009). Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946-950. doi: 10.1038/nm.1999.
188. Sibley, C. H., Chioato, A., Felix, S., Colin, L., Chakraborty, A., Plass, N., et al. (2014). A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2013-204877.[Epub ahead of print].
189. Sieber, M. W., Guenther, M., Jaenisch, N., Albrecht-Eckardt, D., Kohl, M., Witte, O. W., et al. (2014). Age-specific transcriptional response to stroke. Neurobiol. Aging 35, 1744-1754. doi: 10.1016/j.neurobiolaging.2014.01.012.
190. Singh, N., Hopkins, S. J., Hulme, S., Galea, J. P., Hoadley, M., Vail, A., et al. (2014). The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J. Neuroinflammation 11:1. doi: 10.1186/1742-2094-11-1.
191. Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., and Vallance, P. (2004). Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351, 2611-2618. doi: 10.1056/nejmoa041747.
192. Spera, P. A., Ellison, J. A., Feuerstein, G. Z., and Barone, F. C. (1998). IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251, 189-192. doi: 10.1016/s0304-3940(98)00537-0.
193. Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Bilbao, I., et al. (2014). Neutrophils scan for activated platelets to initiate inflammation. Science 346, 1234-1238. doi: 10.1126/science.1256478.
194. Stroemer, R. P., and Rothwell, N. J. (1998). Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J. Cereb. Blood Flow Metab. 18, 833-839. doi: 10.1097/00004647-199808000-00003.
195. Stroke Therapy Academic Industry Roundtable (STAIR). (1999). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30, 2752-2758. doi: 10.1161/01.str.30.12.2752.
196. Suk, S.-H., Sacco, R. L., Boden-Albala, B., Cheun, J. F., Pittman, J. G., Elkind, M. S., et al. (2003). Abdominal obesity and risk of ischemic stroke: the northern manhattan stroke study. Stroke 34, 1586-1592. doi: 10.1161/01.str.0000075294.98582.2f.
197. Suzuki, H., Sozen, T., Hasegawa, Y., Chen, W., and Zhang, J. H. (2009). Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice. Stroke 40, 3872-3875. doi: 10.1161/strokeaha.109.566109.
198. Taka, T., Ohta, Y., Seki, J., Giddings, J. C., and Yamamoto, J. (2002). Impaired flow-mediated vasodilation in vivo and reduced shear-induced platelet reactivity in vitro in response to nitric oxide in prothrombotic, stroke-prone spontaneously hypertensive rats. Pathophysiol. Haemost. Thromb. 32, 184-189. doi: 10.1159/000070425.
199. Takahashi, R., Ishii, K., Shimada, K., Ohkawa, S., and Nishimura, Y. (2010). Hypoperfusion of the motor cortex associated with parkinsonism in dementia with Lewy bodies. J. Neurol. Sci. 288, 88-91. doi: 10.1016/j.jns.2009.09.033.
200. Thored, P., Arvidsson, A., Cacci, E., Ahlenius, H., Kallur, T., Darsalia, V., et al. (2006). Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24, 739-747. doi: 10.1634/stemcells.2005-0281.
201. Thornton, P., McColl, B. W., Greenhalgh, A., Denes, A., Allan, S. M., and Rothwell, N. J. (2010). Platelet interleukin-1αdrives cerebrovascular inflammation. Blood 115, 3632-3639. doi: 10.1182/blood-2009-11-252643.
202. Tosun, D., Schuff, N., and Weiner, M. (2009). An integrated multimodality MR brain imaging study: gray matter tissue loss mediates the association between cerebral hypoperfusion and Alzheimer’s disease. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009, 6981-6984. doi: 10.1109/iembs.2009.5333857.
203. Tsimikas, S., Duff, G. W., Berger, P. B., Rogus, J., Huttner, K., Clopton, P., et al. (2014). Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J. Am. Coll. Cardiol. 63, 1724-1734. doi: 10.1016/j.jacc.2013.12.030.
204. Um, J.-Y., Moon, K.-S., Lee, K.-M., and Kim, H.-M. (2003). Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine 23, 41-46. doi: 10.1016/s1043-4666(03)00183-2.
205. Urbach, A., Bruehl, C., and Witte, O. W. (2006). Microarray-based long-term detection of genes differentially expressed after cortical spreading depression. Eur. J. Neurosci. 24, 841-856. doi: 10.1111/j.1460-9568.2006.04862.x.
206. Utagawa, A., Truettner, J. S., Dietrich, W. D., and Bramlett, H. M. (2008). Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp. Neurol. 211, 283-291. doi: 10.1016/j.expneurol.2008.02.001.
207. Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., et al. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188. doi: 10.1038/nm.2279.
208. VanGilder, R. L., Davidov, D. M., Stinehart, K. R., Huber, J. D., Turner, R. C., Wilson, K. S., et al. (2014). C-reactive protein and long-term ischemic stroke prognosis. J. Clin. Neurosci. 21, 547-553. doi: 10.1016/j.jocn.2013.06.015.
209. Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., and Harris, T. B. (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131-2135. doi: 10.1001/jama.282.22.2131.
210. Vitkovic, L., Bockaert, J., and Jacque, C. (2000). "Inflammatory" cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457-471. doi: 10.1046/j.1471-4159.2000.740457.x.
211. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., et al. (2003). IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. U S A 100, 2645-2650. doi: 10.1073/pnas.0437939100.
212. Wang, X., Barone, F. C., Aiyar, N. V., and Feuerstein, G. Z. (1997). Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28, 155-161. doi: 10.1161/01.str.28.1.155.
213. Wang, J.-Y., Wang, C.-Y., Huang, Y.-S., Chen, P.-F., Huang, K.-Y., Chou, P., et al. (2014). Increased risk of ischemic stroke after hyperosmolar hyperglycemic state: a population-based follow-up study. PLoS One 9:e94155. doi: 10.1371/journal.pone.0094155.
214. Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., et al. (2012). Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379, 2364-2372. doi: 10.1016/S0140-6736(12)60738-7.
215. Wasserman, J. K., Zhu, X., and Schlichter, L. C. (2007). Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res. 1180, 140-154. doi: 10.1016/j.brainres.2007.08.058.
216. Woo, J., Lam, C. W., Kay, R., Wong, A. H., Teoh, R., and Nicholls, M. G. (1990). The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch. Neurol. 47, 1174-1177. doi: 10.1001/archneur.1990.00530110028011.
217. Worrall, B. B., Azhar, S., Nyquist, P. A., Ackerman, R. H., Hamm, T. L., and DeGraba, T. J. (2003). Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34, 790-793. doi: 10.1161/01.str.0000057815.79289.ec.
218. Xu, H.-L., Garcia, M., Testai, F., Vetri, F., Barabanova, A., Pelligrino, D. A., et al. (2014). Pharmacologic blockade of vascular adhesion protein-1 lessens neurologic dysfunction in rats subjected to subarachnoid hemorrhage. Brain Res. 1586, 83-89. doi: 10.1016/j.brainres.2014.08.036.
219. Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., and Kogure, K. (1995). Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26, 676-680. doi: 10.1161/01.str.26.4.676.
220. Yatsuya, H., Folsom, A. R., Yamagishi, K., North, K. E., Brancati, F. L., Stevens, J., et al. (2010). Race-and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 41, 417-425. doi: 10.1161/STROKEAHA.109.566299.
221. Yilmaz, G., Arumugam, T. V., Stokes, K. Y., and Granger, D. N. (2006). Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113, 2105-2112. doi: 10.1161/circulationaha.105.593046.
222. Yudkin, J. S., Stehouwer, C. D., Emeis, J. J., and Coppack, S. W. (1999). C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972-978. doi: 10.1161/01.atv.19.4.972.
223. Zeller, J. A., Lenz, A., Eschenfelder, C. C., Zunker, P., and Deuschl, G. (2005). Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler. Thromb. Vasc. Biol. 25, 1519-1523. doi: 10.1161/01.atv.0000167524.69092.16.
224. Zhang, P., Li, W., Li, L., Wang, N., Li, X., Gao, M., et al. (2012). Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury. Neuroscience 201, 297-306. doi: 10.1016/j.neuroscience.2011.11.005.
225. Zhang, Z.-L., Wu, W.-C., Liu, J.-Q., Yao, Y.-B., Pan, M.-D., Yang, C.-B., et al. (2014). Screening of differentially expressed genes related to ischemic stroke and functional analysis with DNA microarray. Eur. Rev. Med. Pharmacol. Sci. 18, 1181-1188.
226. Zhou, W., Marinescu, M., and Veltkamp, R. (2014). Only very early oxygen therapy attenuates posthemorrhagic edema formation and blood-brain barrier disruption in murine intracerebral hemorrhage. Neurocrit. Care doi: 10.1007/s12028-014-0013-9. [Epub ahead of print].
227. Zhu, Y., Yang, G.-Y., Ahlemeyer, B., Pang, L., Che, X.-M., Culmsee, C., et al. (2002). Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898-3909.
228. Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., et al. (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9, 268-275. doi: 10.1038/nn1629.